Physician profile
Eric R Jarrett
NPI 1295215234
$777.22
in general payments reported to CMS, 2019-2025
10 companies · $385 in 2025
The $385 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44.53 · 2022: $78.38 · 2023: $233 · 2024: $36.45 · 2025: $385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $654.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $654.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $206.12 | 2022-2025 | Miebo, Xiidra |
| Alcon Vision LLC | $193.04 | 2019-2025 | Rocklatan, Clareon, Clareon Panoptix Pro |
| Sight Sciences, INC. | $131.04 | 2023 | Tearcare System |
| Tarsus Pharmaceuticals, INC. | $69.39 | 2025 | Xdemvy |
| Rxsight INC | $64.43 | 2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Light Adjustable Lens (Lal) |
| Novartis Pharmaceuticals Corporation | $37.16 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $29.00 | 2023 | Acuvue |
| Oyster Point Pharma, INC. | $21.25 | 2023 | Tyrvaya |
| Aerie Pharmaceuticals, INC. | $12.91 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $12.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Jarrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.